Griffiths Graham
- SEC CIK
- 0001851630
No open-market purchases or sales filed in the past year.
Current role at each company
- BRNS Barinthus Biotherapeutics plc.Chief Business Officeras of Feb 5, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Griffiths Graham as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2022 (view filing) | Jun 23 | 22 daysLate | Griffiths GrahamChief Business Officer | SSale | −8 | $5.28 | −$42.24 | 0.0%123.2K after | |
| Aug 15, 2022 (view filing) | Aug 12 | 3 days | Griffiths GrahamChief Business Officer | SSale | −5.00K | $4.50 | −$22.5K | −4.1%118.3K after | |
| Aug 17, 2022 (view filing) | Aug 15-16 | 2 days | Griffiths GrahamChief Business Officer | SSale | −3.62K | $4.77 | −$17.3K | −3.1%114.7K after | 2 lots |
| Aug 19, 2022 (view filing) | Aug 17 | 2 days | Griffiths GrahamChief Business Officer | SSale | −500 | $4.76 | −$2.38K | −0.4%114.2K after | |
| Aug 26, 2022 (view filing) | Aug 25 | 1 day | Griffiths GrahamChief Business Officer | SSale | −10.0K | $7.39 | −$73.9K | −8.8%104.2K after |